Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-16T17:10:44.868Z Has data issue: false hasContentIssue false

496 Urinary Exosomal MicroRNA as Early Markers of Diabetic Kidney Disease in African American Adults

Published online by Cambridge University Press:  03 April 2024

Maurice B. Fluitt
Affiliation:
Howard University
Neal Mohit
Affiliation:
Endocrinology and Metabolism, Department of Medicine, Howard University College of Medicine
Mykaiya Sumling
Affiliation:
Department of Biology, Howard University
Baiyee-Ndang Agbor-Baiyee
Affiliation:
Endocrinology and Metabolism, Department of Medicine, Howard University College of Medicine
Kanwal K. Gambhir
Affiliation:
Endocrinology and Metabolism, Department of Medicine, Howard University College of Medicine
Gail Nunlee-Bland
Affiliation:
Diabetes Treatment Center, Howard University Hospital
Constance Mere
Affiliation:
Division of Nephrology, Department of Medicine, Howard University College of Medicine
Maurice B. Fluitt
Affiliation:
Endocrinology and Metabolism, Department of Medicine, Howard University College of Medicine Laboratory of Epigenetic and Metabolic Research, Department of Medicine, Howard University College of Medicine
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

OBJECTIVES/GOALS: This study aimed to characterize urinary exosomal miRNA content in African American adults with diabetic kidney disease. METHODS/STUDY POPULATION: Male and female participants between the ages of 18 and 65 were recruited from the Diabetes Treatment Center and the Nephrology Clinic at the Howard University Hospital. Exosomes were isolated from cleared urine of healthy controls (n=3), type 2 diabetics (n=3), and participants with chronic kidney disease (n=3). The purity and size of isolated microparticles was evaluated using NanoSight technology (30nm to 120nm size range) and western blot analysis for exosome-specific markers (TSG101 and CD81) RESULTS/ANTICIPATED RESULTS: Expression of 5 selected microRNAs, miR-4534, miR-320c, miR-451, miR-362-3p and miR-877-3p were evaluated by qRT-PCR. miR-4534 and miR-451 was increased between healthy controls and the type diabetic group. MiR-320c was increased in the CKD group, in comparison to healthy controls. Conversely, there was no difference in miR-877-5p between the three groups. DISCUSSION/SIGNIFICANCE: These findings will provide insight into the use of circulating miRNAs as early markers of DKD, ultimately creating more effective treatments and preventive measures.

Type
Precision Medicine/Health
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2024. The Association for Clinical and Translational Science